Hypothesis about Transdifferentiation As Backbone of Malignancy

Area of Science:

• Oncology
• Cell Biology
• Developmental Biology

Background:

• Cancer is traditionally viewed as resulting from random mutations and signaling pathway disruptions.
• However, stochastic genomic alterations alone do not fully explain tumor organization, aggressiveness, and evolution.
• A deeper understanding of cancer's complex behavior is needed.

Purpose of the Study:

• To propose a new hypothesis for oncogenesis beyond stochastic mutations.
• To identify key cellular phenotypes driving cancer progression.
• To explore novel therapeutic targets based on these phenotypes.

Main Methods:

• Conceptual hypothesis generation based on observed cancer cell properties.
• Analysis of cancer cell phenotypes in relation to normal physiological functions.
• Identification of potential therapeutic strategies targeting specific cancer cell characteristics.

Main Results:

• Cancer cells exhibit two primary phenotypes: trophoblastic functions (survival, migration, angiogenesis, immune tolerance) and sexual functions (genome maintenance).
• A novel cell reprogramming, termed "malignant transdifferentiation," is hypothesized to drive the shift from precancer to cancer.
• The trophoblastic phenotype is crucial for tumor viability and offers a potential therapeutic target.

Conclusions:

• Malignant transdifferentiation offers a more rational framework for understanding oncogenesis.
• Targeting the trophoblastic phenotype presents a promising therapeutic avenue.
• This approach may lead to novel treatments with reduced toxicity to healthy tissues as the trophoblastic phenotype is not normally expressed postnatally.